Policy & Regulation
14 February 2025 - Australian biotechnology company CSL Limited (ASX:CSL) (USOTC:CSLLY) and US-based mRNA medicines and vaccines company Arcturus Therapeutics (Nasdaq: ARCT) announced on Friday that t...
14 February 2025 - Dermatology specialist Galderma (SWX:GALD) announced on Friday that it has received European Commission approval for Nemluvio to treat moderate-to-severe atopic dermatitis in patien...
14 February 2025 - Australian biotechnology company CSL (ASX:CSL; USOTC:CSLLY) announced on Thursday that it has received approval from the European Commission for ANDEMBRY (garadacimab), the first an...
14 February 2025 - Research-led pharmaceutical company Glenmark Pharmaceuticals Inc USA announced on Thursday that it has introduced Clindamycin Phosphate Foam, 1% in the United States.The product is ...
14 February 2025 - Late-stage pharmaceutical company Moleculin Biotech Inc (Nasdaq:MBRX) said on Thursday that the US Food and Drug Administration (FDA) has provided feedback and guidance on the compa...
14 February 2025 - Precision oncology software company GenomOncology announced on Thursday that it has entered into co-marketing partnership with Pillar Biosciences, a developer of next-generation seq...